{"transactions":[{"id":1071788,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-08T20:15:37.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":4000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest as follows: 1,000,000 shares on August 7, 2026, the remaining 3,000,000 shares in a series of 36 equal monthly installments commencing August 7, 2026, provided the optionee continues to provide services to the Company."}],"balance_after":4000000,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":4000000},"source":{"system":"sec-edgar","filing":"0000886744-25-000062","document":"wk-form4_1754684133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000062/wk-form4_1754684133.xml","form_type":"4"}},{"id":1071787,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-08T20:15:37.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":7000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows: 875,000 shares on February 7, 2026, the remaining 6,125,000 shares in a series of 42 equal monthly installments commencing February 7, 2026, provided the optionee continues to provide services to the Company."}],"balance_after":7000000,"derivative":{"exercise_price":1.3,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":7000000},"source":{"system":"sec-edgar","filing":"0000886744-25-000062","document":"wk-form4_1754684133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674425000062/wk-form4_1754684133.xml","form_type":"4"}},{"id":1678003,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-17T16:05:25.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":695000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 12, 2025 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":695000,"derivative":{"exercise_price":3.11,"expiration_date":"2034-01-11","underlying":"Common Stock","underlying_shares":695000},"source":{"system":"sec-edgar","filing":"0001209191-24-001741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809747/000120919124001741/doc4.xml","form_type":"4"}},{"id":2049814,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T16:04:46.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":651200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 19, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":651200,"derivative":{"exercise_price":2.55,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":651200},"source":{"system":"sec-edgar","filing":"0001209191-23-004218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809747/000120919123004218/doc4.xml","form_type":"4"}},{"id":2118186,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-14T16:13:56.000Z","date":"2022-11-11","kind":"purchase","acquired":true,"shares":25000,"price":1.29,"value":32250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.27 to $1.29 per share, with a weighted average purchase price of $1.29 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-22-056581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809747/000120919122056581/doc4.xml","form_type":"4"}},{"id":2426821,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-25T20:58:10.000Z","date":"2022-01-21","kind":"grant","acquired":true,"shares":423500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 21, 2023 and the remaining underlying shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date."}],"balance_after":423500,"derivative":{"exercise_price":1.11,"expiration_date":"2032-01-20","underlying":"Common Stock","underlying_shares":423500},"source":{"system":"sec-edgar","filing":"0001209191-22-004880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809747/000120919122004880/doc4.xml","form_type":"4"}},{"id":3173546,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2020-04-20T16:41:47.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":252602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Mr. Semerjian was granted stock options pursuant to the Plan. The stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period."}],"balance_after":252602,"derivative":{"exercise_price":19.97,"expiration_date":"2027-04-16","underlying":"Common Stock, Par value $0.01 per share","underlying_shares":252602},"source":{"system":"sec-edgar","filing":"0001104659-20-048727","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920048727/a4.xml","form_type":"4"}},{"id":3173545,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":76791,"kind":"person","name":"Semerjian Harout","position":1,"cik":"0001809747","reported_name":"Semerjian Harout","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, $0.01 par value per share","published_at":"2020-04-20T16:41:47.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":50075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Harout Semerjian was granted restricted stock units pursuant to the Issuer's 2014 Long-Term Incentive Plan (the \"Plan\"). 1/2 of the restricted stock units vest on each of the first and second anniversary of the date of grant, subject to Mr. Semerjian's continued service as the Company's President and Chief Executive Officer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock."}],"balance_after":50075,"source":{"system":"sec-edgar","filing":"0001104659-20-048727","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920048727/a4.xml","form_type":"4"}}]}